This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should Value Investors Buy LabCorp (LH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Growth Stocks to Buy for December 15th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 15th
LabCorp's (LH) Pixel Kit Gets EUA for Over-the-Counter Use
by Zacks Equity Research
This approval is expected to increase access to LabCorp's (LH) COVID-19 testing, thereby broadening its customer base.
3 MedTech Growth Stocks With Solid Prospects for 2021
by Zacks Equity Research
Here are a few MedTech growth stocks poised for a rebound that investors can scoop up to reap profits going into 2021.
Is Laboratory Corporation (LH) a Good Stock to Pick Now?
by Zacks Equity Research
Is Laboratory Corporation (LH) a great pick from the value investor's perspective right now? Read on to know more.
Top Ranked Growth Stocks to Buy for December 9th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 9th
Zacks.com featured highlights include: Whirlpool, TEGNA, LabCorp and Masco Corp
by Zacks Equity Research
Zacks.com featured highlights include: Whirlpool, TEGNA, LabCorp and Masco Corp
LabCorp (LH) Covance Arms Shows Momentum Amid COVID-19 Woes
by Zacks Equity Research
In oncology too, LabCorp (LH) receives a significant award to be the partner of choice for late-stage oncology studies from a major pharmaceutical company.
The Zacks Analyst Blog Highlights: Quest Diagnostics, Laboratory Corporation of America, Hologic, IDEXX Laboratories and Thermo Fisher Scientific
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Quest Diagnostics, Laboratory Corporation of America, Hologic, IDEXX Laboratories and Thermo Fisher Scientific
5 Top PEG-Focused Value Picks to Shield From External Shocks
by Urmimala Biswas
While P/E alone fails to identify a true value stock, PEG helps to find the intrinsic value of a stock.
Top Ranked Growth Stocks to Buy for December 7th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 7th
Looking for a Growth Stock? 3 Reasons Why LabCorp (LH) is a Solid Choice
by Zacks Equity Research
LabCorp (LH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
3 Growth Stocks to Tap the COVID-Driven Shift in MedTech
by Urmimala Biswas
To beat the pandemic blues and maximize capital gains, investors can now scoop up these fundamentally-strong MedTech growth stocks.
Top Ranked Growth Stocks to Buy for December 3rd
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 3rd
The Zacks Analyst Blog Highlights: General Motors, L Brands, LH, Hologic and Qorvo
by Zacks Equity Research
The Zacks Analyst Blog Highlights: General Motors, L Brands, LH, Hologic and Qorvo
LH or CNMD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
LH vs. CNMD: Which Stock Is the Better Value Option?
4 MedTech Stocks Gaining Ground on COVID-19 Test Kit Success
by Debanjana Dey
Here are a few coronavirus-testing MedTech stocks that investors can scoop up to reap profits amid the pandemic-battered stock market situation.
Can Wall Street Sail Through December After a Record November?
by Nalak Das
At this stage, it will be prudent to invest in large-cap stocks with a favorable Zacks Rank and our VGM Score of A or B. These are GM, LB, LH, QRVO, PKI and HOLX.
Zacks.com featured highlights include: Rush, Laboratory Corporation, AGCO and Dollar General
by Zacks Equity Research
Zacks.com featured highlights include: Rush, Laboratory Corporation, AGCO and Dollar General
Is LabCorp (LH) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: Spectrum Brands, Laboratory Corporation, Boise Cascade, ODP and Honda
by Zacks Equity Research
Zacks.com featured highlights include: Spectrum Brands, Laboratory Corporation, Boise Cascade, ODP and Honda
4 Stocks That Stand Out on Attractive Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardships.
5 Best Momentum Picks Using Driehaus Strategy
by Nitish Marwah
After a detailed study of Driehaus' strategy, AAII concluded that it mainly focuses on strong earnings growth rates and impressive prospects to pick potential outperformers.
Top Ranked Growth Stocks to Buy for November 27th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, November 27th
LabCorp (LH) Expands in New Jersey With Clinical Trial Deal
by Zacks Equity Research
LabCorp's (LH) Patient Direct offering will be used here to help in bringing suitable clinical trials to eligible patients directly.